Abstract
The 12-h brain lithium concentration was measured by lithium-7 magnetic resonance spectroscopy in ten manic-depressive patients receiving daily or alternate-day lithium carbonate treatment. The median dose of lithium carbonate was 800 mg in the daily treatment group and 1200 mg in the alternate-day group. Median 12-h serum lithium concentration in the two groups was 0.86 mmoll−1 and 0.55 mmoll−1, respectively, while the corresponding concentration in brain was 0.67 mmoll−1 and 0.52 mmoll−1, respectively. The 12-h brain lithium concentration was independent of lithium dosing schedule (multiple linear regression), but correlated significantly with the 12-h serum lithium concentration (P=0.003; B=0.53, 95% c.l. 0.24–0.82; β=0.83). Thus at identical 12-h serum lithium concentrations the 12-h brain lithium concentration is similar with both treatment regimes. As the risk of manic-depressive relapse during alternate-day lithium treatment is in our experience 3-fold greater than with daily treatment (at similar mean 12-h serum lithium concentration), the findings suggest that the difference in the prophylactic efficacy of the two dosing schedules is unrelated to differences in the 12-h brain lithium concentration.
Similar content being viewed by others
References
American Psychiatric Association (1987) Diagnostic and statistical manual of mental disorders, 3rd rev edn. American Psychiatric Press, Washington, DC
Gonzales RG, Guimaraes AR, Sachs GS, Rosenbaum JF, Garwood M, Renshaw PF (1993) Measurement of human brain lithium in vivo by MR spectroscopy. Am J Nuclear Magnet Res 14:1027–1037
Gyulai L, Wicklund S, Greenstein R, Bauer MS, Ciccione P, Whybrow PC, Zimmerman J, Kovachich G, Alves W (1991) Measurement of tissue lithium concentration by lithium magnetic resonance spectroscopy in patients with bipolar disorder. Biol Psychiatry 29:1161–1170
Jensen HV, Plenge P, Mellerup ET, Davidsen K, Toftegaard L, Aggernæs H, Bjørum N (1995) Lithium prophylaxis of manicdepressive disorder: daily lithium dosing schedule versus every second day. Acta Psychiatr Scand 92:69–74
Johnson FN (1990) Lithium in biomedical science. Editorial. Lithium 1:1–2
Kato T, Takahashi S, Inubushi T (1992) Brain lithium concentrations by7Li- and1H-magnetic resonance spectroscopy in bipolar disorders. Psychiatry Res: Neuroimag 45:53–63
Kato T, Takahashi S, Shioiri T, Inubushi T (1993) Brain lithium concentrations measured with lithium-7 magnetic resonance spectroscopy in patients with affective disorders: relationship to erythrocyte and serum concentrations. Biol Psychiatry 33:147–152
Kato T, Takahashi S, Shioiri T, Inubushi T (1994) Brain lithium concentration measured with lithium-7 magnetic resonance spectroscopy: a review. Lithium 5:75–81
Komoroski RA, Newton JEO, Walker E, Cardwell D, Jagannathan NR, Ramapsasad S, Sprigg J (1990) In vivo NMR spectroscopy of lithium-7 in humans. Magnet Res Med 15:347–356
Komoroski RA, Newton JEO, Sprigg JR, Cardwell D, Mohanakrishnan P, Karson CN (1993) In vivo7Linuclear magnetic resonance study of lithium pharmacokinetics and chemical shift imaging in psychiatric patients. Psychiatry Res 50:67–76
Kusnir T, Itzchak Y, Valevski A, Lask M, Modai I, Navon G (1993) Relaxation times and concentrations of Li in the brain of patients receiving lithium therapy. NMR Biomed 6:39–42
Mellerup ET, Plenge P, Rafaelsen OJ (1987) Renal and other controversial adverse effects of lithium. In: Meltzer HY (ed) Psychopharmacology: the third generation of progress. Raven Press, New York, pp 1443–1448
Plenge P, Stensgaard A, Jensen HV, Thomsen C, Mellerup ET, Henriksen O (1994) 24-hour lithium concentration in human brain studied by Li-7 magnetic resonance spectroscopy. Biol Psychiatry 36:511–516
Renshaw PF, Wicklund S (1988) In vivo measurement of lithium in humans by nuclear magnetic resonance spectroscopy. Biol Psychiatry 23:465–475
World Health Organization (1965) International classification of diseases, 8th edn. WHO, Geneva
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Jensen, H.V., Aggernæs, H., Plenge, P. et al. Twelve-hour brain lithium concentration in lithium maintenance treatment of manic-depressive disorder: daily versus alternate-day dosing schedule. Psychopharmacology 124, 275–278 (1996). https://doi.org/10.1007/BF02246668
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF02246668